# Acceptability, Safety, and Use of Daily Truvada Pre-Exposure Prophylaxis in Adolescents

> **NCT02213328** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 148 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Truvada

## Key facts

- **NCT ID:** NCT02213328
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2017-03-06
- **Final completion:** 2017-03-06
- **Target enrollment:** 148 (ACTUAL)
- **Last updated:** 2023-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02213328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02213328, "Acceptability, Safety, and Use of Daily Truvada Pre-Exposure Prophylaxis in Adolescents". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02213328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*